BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 12055239)

  • 1. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
    Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
    J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides.
    Schirmbeck R; Fissolo N; Chaplin P; Reimann J
    J Immunol; 2003 Aug; 171(3):1240-6. PubMed ID: 12874211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen.
    Schirmbeck R; Melber K; Reimann J
    Int Immunol; 1999 Jul; 11(7):1093-102. PubMed ID: 10383942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells.
    Stober D; Trobonjaca Z; Reimann J; Schirmbeck R
    Eur J Immunol; 2002 Apr; 32(4):1099-108. PubMed ID: 11920577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen.
    Wieland A; Riedl P; Reimann J; Schirmbeck R
    Vaccine; 2009 Dec; 28(1):114-9. PubMed ID: 19818719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen.
    Schirmbeck R; Zheng X; Roggendorf M; Geissler M; Chisari FV; Reimann J; Lu M
    J Immunol; 2001 Jan; 166(2):1405-13. PubMed ID: 11145726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
    Geluk A; van Meijgaarden KE; Franken KL; Drijfhout JW; D'Souza S; Necker A; Huygen K; Ottenhoff TH
    J Immunol; 2000 Dec; 165(11):6463-71. PubMed ID: 11086086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.
    Sette AD; Oseroff C; Sidney J; Alexander J; Chesnut RW; Kakimi K; Guidotti LG; Chisari FV
    J Immunol; 2001 Jan; 166(2):1389-97. PubMed ID: 11145724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens.
    Schirmbeck R; Reimann J; Kochanek S; Kreppel F
    Mol Ther; 2008 Sep; 16(9):1609-16. PubMed ID: 18612271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.
    Schirmbeck R; Böhm W; Ando K; Chisari FV; Reimann J
    J Virol; 1995 Oct; 69(10):5929-34. PubMed ID: 7666497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant.
    Ulrich JT; Cieplak W; Paczkowski NJ; Taylor SM; Sanderson SD
    J Immunol; 2000 May; 164(10):5492-8. PubMed ID: 10799917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses.
    Roh S; Lee YK; Ahn BY; Kim K; Moon A
    Virus Res; 2001 Jan; 73(1):17-26. PubMed ID: 11163641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
    Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
    Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
    Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
    J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination.
    Riedl P; El-Kholy S; Reimann J; Schirmbeck R
    J Immunol; 2002 Aug; 169(3):1251-60. PubMed ID: 12133946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen.
    Schirmbeck R; Wild J; Reimann J
    Eur J Immunol; 1998 Dec; 28(12):4149-61. PubMed ID: 9862351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
    Fomsgaard A; Nielsen HV; Bryder K; Nielsen C; Machuca R; Bruun L; Hansen J; Buus S
    Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.